Q4 2025 Earnings Call February 26, 2026 10:00 AM ESTCompany ParticipantsJennifer Harper - VP of Investor Relations ...
Throughout the year, we saw robust net product sales revenue growth, steady prescription growth, and strong market share growth across all of our approved indications and formulations of XEREVE, or ...
Two Kansas regulatory bodies issued a joint statement Wednesday after receiving complaints about practices at intravenous ...
Employers use carve-outs and cash-pay channels to reduce GLP-1 costs, while Scripta’s Navigator helps members compare prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results